ASH

ASH Biotechnology IONS OTSKF OTSKY Uncategorized

Ionis, Otsuka win EU nod for hereditary angioedema therapy

Jan 21, 2026

ACLX ASH Biotechnology GILD JNJ LEGN Uncategorized

Legend Biotech Arcellx rise after FDA draft guidance on multiple myeloma trials

Jan 20, 2026